{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=ALL&page=49", "query": { "condition": "ALL", "page": 49 }, "page_size": 10 }, "pagination": { "page": 49, "page_size": 10, "total_count": 2125, "total_pages": 213, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=ALL&page=50&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=ALL&page=48&page_size=10" }, "source": "local", "last_synced_at": "2026-10-18T02:15:42.787Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06567015", "title": "Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Non-small Cell Lung Cancer (NSCLC)" ], "interventions": [ { "name": "STX-241", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pierre Fabre Medicament", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 171, "start_date": "2024-09-17", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-17T02:05:57.195Z", "location_count": 2, "location_summary": "Nashville, Tennessee • Houston, Texas", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06567015" }, { "nct_id": "NCT06043817", "title": "First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "EGFR/HER2 Exon 20 Insertion Mutation", "NSCLC", "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "STX-721/PFL-721 (3 dose levels)", "type": "DRUG" }, { "name": "STX-721/PFL-721 (Escalated)", "type": "DRUG" }, { "name": "STX-721/PFL-721 (RP2D)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pierre Fabre Medicament", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 345, "start_date": "2023-09-26", "completion_date": "2029-12-01", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-16T15:09:49.672Z", "location_count": 9, "location_summary": "Duarte, California • Huntington Beach, California • Irvine, California + 6 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06043817" }, { "nct_id": "NCT05918640", "title": "Lurbinectedin in FET-Fused Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Desmoplastic Small Round Cell Tumor", "Ewing Sarcoma", "Pediatric Cancer", "Undifferentiated Sarcoma" ], "interventions": [ { "name": "Lurbinectedin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 63, "start_date": "2023-07-27", "completion_date": "2029-07-30", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-14T06:01:00.115Z", "location_count": 6, "location_summary": "Los Angeles, California • Iowa City, Iowa • Boston, Massachusetts + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05918640" }, { "nct_id": "NCT05837767", "title": "A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bladder Cancer", "Gastrointestinal Adenocarcinoma", "Gastrointestinal Cancer", "Gastrointestinal Squamous Cell Cancer", "Invasive Ductal Breast Carcinoma", "Invasive Ductal Breast Carcinoma Stage IV", "Lobular Breast Carcinoma", "Lobular Breast Carcinoma Stage IV", "Melanoma", "Metastatic Solid Tumor", "NSCLC", "Non Small Cell Lung Cancer", "Pancreatic Cancer", "Renal Cell Carcinoma", "Sarcoma" ], "interventions": [ { "name": "Palliative radiotherapy", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2023-07-24", "completion_date": "2027-07-24", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-14T21:30:23.038Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05837767" }, { "nct_id": "NCT05245500", "title": "Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor", "Malignant Peripheral Nerve Sheath Tumors", "Mesothelioma", "Non Small Cell Lung Cancer", "Pancreatic Adenocarcinoma", "Solid Tumor" ], "interventions": [ { "name": "MRTX1719", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 336, "start_date": "2022-06-09", "completion_date": "2027-12-10", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-07T19:08:39.461Z", "location_count": 24, "location_summary": "Phoenix, Arizona • Lone Tree, Colorado • Jacksonville, Florida + 20 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Lone Tree", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05245500" }, { "nct_id": "NCT04913285", "title": "A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Melanoma", "Non-small Cell Lung Cancer", "Solid Tumor, Adult" ], "interventions": [ { "name": "KIN-2787", "type": "DRUG" }, { "name": "KIN-2787 and binimetinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pierre Fabre Medicament", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 400, "start_date": "2021-08-04", "completion_date": "2029-03-30", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-14T12:17:36.360Z", "location_count": 15, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04913285" }, { "nct_id": "NCT07586618", "title": "First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Lymphoblastic Leukemia ALL", "Lymphoblastic Lymphoma" ], "interventions": [ { "name": "4A10", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allterum Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2026-06-01", "completion_date": "2028-09", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-18T02:15:42.787Z", "location_count": 7, "location_summary": "Aurora, Colorado • Indianapolis, Indiana • New York, New York + 4 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "New York", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07586618" }, { "nct_id": "NCT07091279", "title": "Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Aggression", "Autism Spectrum Disorder", "Challenging Behaviour", "Self-injury", "Severe Disruptive Behaviour Disorders" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jeremy Veenstra-vanderweele", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 60, "start_date": "2026-01-30", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-13T23:10:06.204Z", "location_count": 2, "location_summary": "Staten Island, New York • White Plains, New York", "locations": [ { "city": "Staten Island", "state": "New York" }, { "city": "White Plains", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07091279" }, { "nct_id": "NCT06414460", "title": "Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Locally Advanced/Metastatic Solid Tumors" ], "interventions": [ { "name": "ISM3412", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "InSilico Medicine Hong Kong Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 146, "start_date": "2025-04-25", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-13T19:15:50.149Z", "location_count": 5, "location_summary": "Denver, Colorado • New Haven, Connecticut • Indianapolis, Indiana + 2 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06414460" }, { "nct_id": "NCT07795749", "title": "Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Appendiceal Adenocarcinoma", "Colorectal Adenocarcinoma", "Esophageal Carcinoma", "Gastric Cancer (Diagnosis)", "Hepatobiliary Carcinoma in Situ", "Small Bowel Adenocarcinoma" ], "interventions": [ { "name": "Paclitaxcel Q3W", "type": "DRUG" }, { "name": "Paclitaxel Q2W", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Irvine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2026-08-04", "completion_date": "2029-08-31", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-01T07:53:41.308Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07795749" } ] }